ESMO Preceptorship on Breast Cancer 2019: Lisbon
Application deadline: Saturday 27 July 2019
The most influential oncology meeting in Europe, in partnership with the EACR.
IMPORTANT! Beware of fraudulent websites offering registration or accommodation!
The ESMO Executive Board Elections 2019 are now closed. View the results and read what the newly elected Executive Board members say about their appointment.
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Jorge Reis-Filho and Caterina Marchiò explain that precision medicine delivery posed a question on how to screen for genetic alterations present in many tumour types but at very low prevalence. They addressed such unmet need in terms of detection of NTRK fusions together with a group of experts on behalf of the ESMO Translational Research and Precision Medicine Working Group.
17 Jul 2019
The programme is now available online!
17 Jul 2019
Collecting data for better representation of genetic variability
16 Jul 2019
Recent study in France suggested that the risk of meningioma, although very low, may be increased when taking high doses of cyproterone for a long...
15 Jul 2019
Results from a randomised trial in preventing herpes zoster in immunocompromised patients after autologous haematopoietic stem cell transplantation
12 Jul 2019
Approval is based on efficacy and safety results from Part 2 of the STORM study
11 Jul 2019
KLHL11 identified as anovel paraneoplastic autoantibody
Valencia, Spain
18 Jul
- 23 Jul
2019
Oxford, United Kingdom
23 Aug
- 25 Aug
2019
Barcelona, Spain
30 Aug
- 31 Aug
2019
Naples, Italy
01 Sep
- 06 Sep
2019
Singapore
04 Sep
- 05 Sep
2019
Singapore
06 Sep
- 07 Sep
2019
